Avadel Pharmaceuticals PLC. (NASDAQ:AVDL) Announces A Corporate Restructuring Plan To Maximize On The Value Of FT218 – FDA Headlines
Avadel Pharmaceuticals PLC. (NASDAQ:AVDL) lost 10.67% in the previous trading session here is the reason why the stock is hitting new lows. The pharmaceutical company has also set records right regarding its corporate restructuring activities, which have been under massive speculation. According to the companys interim Chief Executive Officer, Greg Divis, the restructuring will…